Picard Medical names Chairman Richard Fang interim CEO after Schnegelsberg steps down

Picard Medical, Inc.

Picard Medical, Inc.

PMI

0.00
  • Picard Medical named Executive Chairman Richard Fang interim CEO, effective June 18, 2026, while it searches for a permanent chief executive.
  • Patrick NJ Schnegelsberg stepped down as CEO and resigned from the board, effective June 18, 2026; the exit was not tied to operational disagreements.
  • Fang is a founder and managing partner of Hunniwell Lake Ventures; he previously founded Reach Surgical and held medical-device roles including at Johnson & Johnson.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-021504), on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.